PHI with Chronic nephritis with necrotizing glomerulitis
How does this condition affect your private health insurance?
Chronic nephritis with necrotizing glomerulitis is a severe, progressive kidney disorder characterized by persistent inflammation and tissue death (necrosis) within the glomeruli, the tiny filtering units of the kidneys. This condition often leads to rapid decline in renal function, presenting with symptoms like hematuria (blood in urine), proteinuria (protein in urine), hypertension, and edema. It can be primary or secondary to systemic autoimmune diseases, such as vasculitis or lupus. The progressive damage impairs the kidneys' ability to filter waste products, leading to chronic kidney disease and potentially end-stage renal failure, necessitating dialysis or kidney transplantation. Early diagnosis and aggressive immunosuppressive therapy are crucial but the prognosis often remains guarded.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months, often requiring hospitalization and intensive care
Duration of Illness (Lifetime)
Chronic disease, lifelong management, often leading to end-stage renal disease
Cost of Treatment (Initial)
Tens of thousands to hundreds of thousands of USD (e.g., $50,000 - $200,000) for initial acute treatment including hospitalization and specialized therapies
Cost of Treatment (Lifetime)
Hundreds of thousands to millions of USD, especially if progressing to end-stage renal disease requiring dialysis or kidney transplantation
Mortality Rate
Moderate to high (e.g., 10-30% within 5 years, significantly higher with progression to end-stage renal disease and complications)
Risk of Secondary Damages
Very high (>80%), leading to chronic kidney disease, end-stage renal disease, cardiovascular complications, severe hypertension, anemia, and other systemic issues
Probability of Full Recovery
Low (e.g., <20% for complete recovery without residual kidney damage or long-term consequences; remission is more common than full recovery)
Underlying Disease Risk
Moderate to high (e.g., 30-60%), often associated with systemic autoimmune diseases like ANCA-associated vasculitis, lupus nephritis, or other systemic inflammatory conditions